With increasingly complex regulatory requirementsespecially in ESG, investors are overwhelmed with arapidly increasing amount of unstructured information inthe form of annual and ESG reports.

On the other hand,issuers face growing pressure to disclose and verify moredata. These factors combined with manual reportingworkflows compound the inefficiencies in capitalmarkets. Wizpresso offers capital markets SaaSunderpinned by cutting edge NLP and deep learningtechnology to tackle these challenges.

Our solutionsaugment capital markets research and due diligenceworkflows. For example,

Factify, our legal verificationsoftware, can save the issuer up to 75% time fromverifying information disclosed in prospectuses andfilings.

Discovery, our market intelligence software,enables investors to screen company and extract ESGinsights from financial reports and regulated disclosures.Wizpresso aims to enhance the awareness and use ofESG disclosure data amongst retail and professionalinvestors.

Founded in 2017 and headquartered in Xi’an, WEDOfocuses on developing 3D printed titanium alloyimplants, biodegradable implants, and polymerimplants by leveraging advanced medial innovation.

Products are used in the surgical treatment of cervical and lumbar spine diseases, mid-termfemoral head necrosis, spinal tumor, severe trauma,tuberculosis, severe infection, long-bone segmentaldefects, etc.

Since 2020, WEDO has made major breakthroughsin the field of bone defect repair. Combining tissueengineering and 3D printing technology, WEDOdeveloped new bone repair materials and products,which overcame the limitations of high infectionrate, long treatment time, and complications inconventional materials.

DreamTec Research Limited owns the exclusive proprietary technology, which can produce various recombinant proteins with large-scale and efficient technology. Recombinant proteins are oligopeptides or polypeptides (proteins) produced in different prokaryotic or eukaryotic hosts (such as bacteria, mammalian cells, and plant cells) in a controlled form via modification of a special DNA vector with the recombinant DNA technology.

DreamTec has a series of genetic programming systems to produce recombinant proteins, which can produce different recombinant proteins including interleukin-3 (IL-3), interleukin-6 (IL-6), transforming growth factor-β2 (TGF-β2), glucagon-like peptide-1 (GLP-1), and stem cell factor (SCF) via fermentation technology for bacteria and mammalian cells as well as large-scale FPLC and HPLC purification technology. We have successfully developed different series of cosmetic medicine and health products such as restorative masks, biological tooth repair essence, and microneedle infusion solution for skin remodeling by utilizing different oligopeptides and polypeptides.

Moreover, the scientific research team of DreamTec has successfully developed edible probiotics containing different compounds and growth factors beneficial to the human body. In order to develop high-end healthcare products, meet the people’s demand for high-end healthcare products, and reduce the government’s medical costs, we look forward to collaborating with scholars in China on different research projects that can be industrialized for the benefit of society and contribute to China’s economic and innovative scientific development.

Vista Innotech (VIT), a start-up company under HKSTP Leading Enterprises Acceleration Programme (LEAP). We are a team with experts from various engineering fields, including mechanical, electrical and optical.

Our one-stop anti-shaking Micro Gimbel Stabilizer (MGS) is the smallest gimbal with 50+ international filed patents and excellent anti-shaking performance outperforming latest iPhone by up to 4 times. Along with our proprietary auto-calibration software, compact sizes small enough for embedding in smartphones, low cost, and easily integrated designs, we can set the best anti-shaking standards for camera modules of most mobile devices.

We successfully completed our angel round funding and became one of the portfolio companies under Particle X in 2020. We also joined LEAP in 2021 and won 6 awards in half year, including Geneva Invention 2022 Silver Medal.

To celebrate the 25th anniversary of Hong Kong’s handover. Gusto Collective has joined hands with the LCSD to promote immersive Art-Tech exhibition to engage audiences in Hong Kong in exploring the segway between science and art with meta human artist MonoC.